8 1 5 a r t i c l e s RNA polymerase II (Pol II) activity can be regulated at several steps of the transcription cycle, including preinitiation, DNA melting, initiation, promoter clearance and elongation 1 . One well-studied case of regulation at the elongation step involves the HIV-1 transactivator of transcription (Tat) protein, which relieves a block to elongation at the viral promoter 2-4 and functions after recruitment of the basal transcription machinery 5 . Without Tat, Pol II is stalled soon after initiation and is inefficiently converted to the processive form 6,7 , a step requiring the recruitment of positive transcription elongation factor b (P-TEFb) to a promoter-proximal RNA element (TAR) on the nascent HIV-1 pre-mRNA 8 . P-TEFb is composed of cyclinT1 (CycT1) and cyclin-dependent kinase 9 (Cdk9) (refs. 8-10) and is used at many promoters, including HIV-1, to phosphorylate Ser2 residues in the C-terminal domain (CTD) of Pol II 11-13 , thereby converting a nonphosphorylated form (Pol IIa) to a hyperphosphorylated form (Pol IIo) that engages in productive elongation [14] [15] [16] . P-TEFb catalytic activity is tightly controlled in cells by switching the equilibrium between two states: an active P-TEFb form, which can be recruited to chromatin by interacting with Brd4 (refs. 17, 18) , and an inactive ribonucleoprotein form containing the 7SK snRNP, composed of 7SK snRNA, Hexim1 and Larp7/Pip7S, in addition to the CycT1 and Cdk9 subunits 10, 19 . Even though P-TEFb can be recruited to chromatin via Brd4, there is evidence that Tat can directly recruit P-TEFb to the HIV-1 promoter independently of Brd4 (ref. 18). The inactive P-TEFb form also can also associate with a methylphosphate capping enzyme (Mepce), whose activity stabilizes the 7SK snRNA 20 .
a r t i c l e s
Assembly of Tat and P-TEFb-7SK snRNP at the HIV-1 promoter
Given that Tat and P-TEFb-7SK snRNP associate with Pol II, and given that Tat remodels the 7SK snRNP complex, we next examined Tat, P-TEFb-7SK snRNP and cofactor occupancy at the HIV-1 promoter by chromatin immunoprecipitation (ChIP) using eight PCR primer pairs ( Fig. 2a) in a stable reporter cell line with or without transfected Flag-tagged Tat (Supplementary Fig. 1 ). This highresolution ChIP protocol provides a reasonably comprehensive view of factor occupancy in and around the HIV-1 promoter ( Fig. 2a,b) , extending previous studies of cofactor recruitment 5, 25, 26 and, for the first time, permits us to locate Tat. The ChIP signal for Tat was undetectable in mock transfections or in cells transfected with a nonfunctional Tat mutant ( Supplementary Fig. 2 ) but showed a high signal-to-noise ratio at specific regions when transfected with optimal levels of Tat (Fig. 2b) . As anticipated, Tat occupies the transcribed region where TAR is located (+103) but, notably, was present at almost equivalent levels in the core promoter (−75) (lower by a factor of 1.5). Tat also was seen in the downstream transcribing region, consistent with previous reports that Tat travels with the elongating Pol II 27 . High binding specificity is indicated by the absence of signal in the far upstream and downstream regions, −845 and +4490, respectively, and the relatively low signal at −352.
Other factors also show tight binding distributions. In the absence of Tat, the basal transcription factors Sp1 and TBP were recruited exclusively to the core promoter (−75, Fig. 2b) , where their binding sites are known to reside 28, 29 (Supplementary Fig. 3 ). Occupancy of both Sp1 and TBP was stimulated modestly (increased by a factor of 2-2.5) by Tat, consistent with its previously reported effects on basal factor recruitment 5 and with our observed location of Tat in the same −75 region. Because we observed very little Tat in the upstream enhancer region (−352), a region also unnecessary for Tat activation in transcription reporter assays ( Supplementary Fig. 3 ), it appears that Tat is recruited to and functions at the core promoter and downstream elements and not at the distal enhancer.
In the absence of Tat, both P-TEFb subunits (CycT1 and Cdk9) were found at moderate levels predominantly in the core promoter region (−75) ( Fig. 2b) . Notably, like P-TEFb, we also observed the 7SK snRNP components Hexim1 and Larp7 predominantly in the core promoter, consistent with their copurification in Pol II complexes (Fig. 1a,b) . Because Larp7 is an integral component of the 7SK snRNP, and because depletion of Larp7 leads to the degradation of 7SK snRNA 30 , we infer that 7SK snRNA also is recruited to the HIV-1 promoter (see below).
Upon Tat activation, CycT1 and Cdk9 occupancy increased by a factor of 2-3 at −75 and by a factor of ~11 at +103 ( Fig. 2b) , implying that Tat further enhances P-TEFb recruitment at or near the transcription start site (TSS), and also increased P-TEFb occupancy by a factor of 6-22 through the transcribing unit, as expected given that P-TEFb also is associated with elongating Pol II complexes [31] [32] [33] [34] . Notably, while occupancy of the P-TEFb subunits increased upon Tat activation, we observed an especially large decrease in the 7SK snRNP components concomitantly in the +103 region (lower by a factor of ~12 for Larp7 and by a factor of ~15 for Hexim1) but not at the core promoter (lower by a factor of ~1.3 for Larp7 and by a factor of ~2 for Hexim1). These results are consistent with a model in which Tat binding to the nascent RNA is coupled to the dissociation of 7SK snRNP and activation of the P-TEFb kinase (see below). P-TEFb can be recruited to chromatin through interaction with Brd4 (refs. 17, 18) , which is capable of stimulating HIV-1 transcription in a Tat-independent manner 18 . In our ChIP assays, Brd4 was constitutively present throughout the entire promoter and transcribing region, and its profile was unchanged by Tat ( Fig. 2b) , in agreement with reports suggesting that the interaction between Brd4 and P-TEFb is not essential for Tat activation 18 .
Previous observations that Tat and P-TEFb interact with Pol II and HIV-1 preinitiation complexes (PICs) 31, 32, 34, 35 raised the possibility that they assemble with a promoter-paused Pol II, like some pre-mRNA processing factors 36 , and may not be recruited to the HIV-1 promoter directly through TAR recognition. Therefore, we analyzed total Pol II and CTD phosphoisoforms by ChIP (Fig. 2b) . In the absence of Tat, total Pol II was localized almost exclusively to the core promoter region (−75), and its occupancy rose by a factor of ~2 upon Tat activation and by a factor of 8-24 throughout the transcribing region ( Fig. 2b) . We detected no Pol II at the upstream enhancer region (−352), suggesting that chromatin looping between enhancer elements and the core promoter is not a major feature of Tat activation. Using Pol II CTD-specific antibodies to phosphorylated Ser5 (initiating) or Ser2 (elongating) Pol II, we observed exclusively the S5P CTD form, but not the S2P CTD, at the core promoter without Tat (Fig. 2b) . Upon Tat activation, the level of S5P CTD at the promoter increased by a factor of 5-6, suggesting that preloaded Pol II is not completely phosphorylated on Ser5 CTD residues before Tat Figure 1 Inactive P-TEFb assembles into Pol II complexes, and Tat activates its catalytic activity. (a) Partial composition of Pol II complexes purified on a transcription factor IIS (TFIIS) affinity resin 22 was assessed by comparing western blots of proteins and levels of 7SK snRNA eluted from a GST-TFIIS column to those from HeLa whole cell extracts (WCE) and a GST control column. The TFIIS used was an N-terminal fragment that possesses the same activity as full-length TFIIS 22 . Right, the purified Coomassie-stained recombinant GST and GST-TFIIS proteins used for the columns. Arrow, position of full-length CycT1. (b) GST-TFIIS eluted complexes were loaded onto a Sepharose CL-2B gel filtration column, and the single eluted peak was immunoprecipitated (IP) by either anti-Cdk9 or mock (normal rabbit IgG) antibodies. Both precipitates, either incubated or not with purified GST-Tat, were used in kinase assays with a GST-CTD substrate and analyzed by western blot with the H5 antibody, which recognizes Pol IIo. AU, absorbance units (scale 0-1). (c) Pol II complexes were purified on a TFIIS affinity resin, incubated with GST or GST-Tat in vitro and immunoprecipitated with anti-Cdk9 antibody, and the presence of P-TEFb (CycT1 and Cdk9) and 7SK snRNP (Hexim1 and Larp7) was monitored by western blot.
a r t i c l e s activation, in agreement with a role of Tat in enhancing Ser5 phosphorylation in reconstituted transcription complexes in vitro 33 . The levels of both the S5P CTD and S2P CTD forms increased markedly (by a factor of 10-100) throughout the transcribing unit, coincident with enhanced recruitment of P-TEFb to the promoter and release of the 7SK snRNP ( Fig. 2b) . The patterns of Pol II accumulation at the core promoter are consistent with a paused Pol II model 7 , where Pol II pauses near the promoter before TAR is fully transcribed 6 and allows Tat to operate at postinitiation steps. The association of RNA-binding proteins with DNA observed in ChIP assays sometimes relies on an RNA bridge 37 . Thus, we next performed ChIP experiments on RNase-treated extracts ( Fig. 2c) to determine if Tat and P-TEFb-7SK snRNP recruitment to the promoter depend on RNA (TAR or other RNAs). RNase treatment reduced Tat occupancy at the core promoter (−75) by a factor of ~2.5 but much more substantially where TAR is positioned (+103) (lower by a factor of ~18) ( Fig. 2c) , likely reflecting a loss of binding to the nascent TAR, whereas Sp1, TBP, Brd4 and Pol II occupancy were nearly unchanged (compare Fig. 2b,c) . In marked contrast, CycT1, Cdk9, Hexim1 and Larp7 occupancy were markedly reduced by RNase treatment (lower by a factor of 2-16), suggesting that all may assemble as part of the entire 7SK snRNP complex. Unexpectedly, the RNAse treatment caused only a small reduction in the levels of S2P CTD Pol II throughout the transcribing region despite the nearly total loss of CycT1 and Cdk9, suggesting that P-TEFb may still somehow associate with elongating Pol II in a manner that is affected by RNA ( Fig. 2c) . We also found the Tat activation domain alone, lacking the RNA-binding domain, at the core promoter (lower by a factor of 3 compared to Tat occupancy) and even in the absence of TAR ( Supplementary Fig. 4 ), suggesting that Tat can assemble at the promoter through protein-protein interactions alone, although full occupancy requires protein-RNA contacts as well.
TAR-independent recruitment of Tat and P-TEFb-7SK snRNP to the promoter
Because we observed Tat and P-TEFb-7SK snRNP complexes in regions of the HIV-1 promoter upstream of the TSS, we wished to determine if TAR was necessary for their recruitment. We constructed a stable reporter cell line containing a TAR deletion and monitored factor occupancy with or without transfected Flag-tagged Tat (Fig. 2d) . First, Tat was still loaded at the promoter region (−75), showing a reduction in occupancy by a factor of only 2 when compared with TAR, whereas occupancy at +103 was virtually lost (lower by a factor of ~27). Second, CycT1, Cdk9, Hexim1 and Larp7, along with the basal transcription factors Sp1 and TBP, all were still loaded at the core promoter (−75) without TAR (compare Fig. 2b,d) , showing that TAR is not simply a binding site for Tat-P-TEFb recruitment. Third, Hexim1 and Larp7 were no longer displaced at +103 upon Tat activation, suggesting that the interaction of Tat-P-TEFb with TAR at the viral promoter is required to eject these subunits and, presumably, to activate Cdk9. Finally, we no longer found CycT1 and Cdk9 throughout the transcribing region, nor did we find Pol II CTD Ser2 phosphorylation, providing compelling evidence that Hexim1 and Larp7 are not displaced from the viral promoter without TAR, and Cdk9 thus is not activated (Fig. 2d) .
Tat assembles with 7SK snRNP in vivo
Previous studies have shown that Tat releases Hexim1 from inactive P-TEFb-7SK snRNP complexes 23 HIV-1 promoter a r t i c l e s binding to a stem loop near the 5′ end of 7SK snRNA where Hexim1 also binds 30, 38 , thus competing with Hexim1 for CycT1 binding, as previously shown in vitro 39 . Given that Tat and 7SK snRNP, including Hexim1, are recruited to the HIV-1 promoter, we wished to further assess which interactions occur between Tat and the 7SK snRNP before promoter binding. We performed standard immunoprecipitation experiments with Flag-tagged Tat expressed stably in a HEK 293 cell line and also performed cross-linking studies similar to those used for ChIP to trap potentially less stable or transient complexes 37 with P-TEFb-7SK snRNP (Fig. 3) . In the absence of cross-linking, we detected CycT1, Cdk9 and Larp7, along with Tat, by western blot and 7SK snRNA by RT-PCR (Fig. 3, lane 4) . Notably, in the formaldehyde-cross-linked sample, we observed the same components but also found Hexim1 and about seven-fold more 7SK snRNA but no detectable U6 snRNA (Fig. 3, lane 5) . We observed no bound proteins in control HEK 293 cells not expressing Tat (Fig. 3, lane 6) , and the cross-linking step did not affect the levels of input protein (Fig. 3, lanes 1-3) . These results suggest that Tat and P-TEFb-7SK snRNP may form preassembled complexes before being recruited to the HIV-1 promoter.
Determinants for 7SK snRNP recruitment to the promoter
To provide direct evidence that P-TEFb-7SK snRNP complexes occupy the HIV-1 promoter, we purified transcription PICs using biotinylated templates and streptavidin-coated magnetic beads (Fig. 4a, top) . Indeed, all components of the inactive P-TEFb complex were associated with the HIV-1 template, along with basal transcription factors (Sp1 and TBP), but not with a control promoterless template (Fig. 4a, bottom) . We measured the activity of the purified HIV-1 PICs by in vitro transcription and primer extension and obtained the expected transcription product, which was Supplementary Fig. 5 ), and ChIP assays were performed using the antibodies indicated. Values represent the percentage of input DNA immunoprecipitated (IP DNA) and are the average of four independent PCRs from two separate immunoprecipitations from two independent cell cultures. All s.d. are <15%. Figure 3 Tat assembles with the 7SK snRNP in vivo. RNA immunoprecipitation was performed using antibodies to Flagtagged Tat. Western blots (upper panels) indicate that components of P-TEFb (CycT1 and Cdk9) and 7SK snRNP (Larp7 and Hexim1) form a complex with Tat. Lower two panels, RT-PCR was used to detect 7SK and U6 snRNAs. a r t i c l e s inhibited by α-amanitin (Fig. 4a, bottom) , confirming that the purified PICs were competent for Pol II transcription.
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The ChIP occupancy profile of Tat, basal transcription factors and P-TEFb-7SK snRNP components (Fig. 2) indicate that the core promoter region is important for their recruitment. To test whether the core promoter is sufficient for transcription complex assembly in vitro and transcription activation, we synthesized a minimal template containing the Sp1, TATA, initiator and TAR elements (base pairs −105 to +120) but lacking the 5′ enhancer region (core HIV-1, Fig. 4b) .
Indeed, PIC assembly with the core template was identical to that with the full-length promoter (Fig. 4b) , as was Tat activation in transcription reporter assays (Supplementary Fig. 3 ). Deleting the Sp1 or TATA elements reduced or eliminated all interactions, basal transcription and Tat activation ( Fig. 4b and Supplementary Fig. 3 ), suggesting that the basal machinery, Sp1 (as suggested previously 29, 40, 41 ) and P-TEFb-7SK snRNP all contribute to forming a Tat-responsive complex.
We further assessed the in vivo relevance of Sp1 to Tat assembly at the promoter by depleting Sp1 with RNA interference (RNAi) and monitoring factor occupancy by ChIP. Sp1 occupancy at the HIV-1 promoter decreased by a factor of ~8 (Fig. 4c) , and Tat activity in transcription reporter assays decreased by a factor of ~10 ( Supplementary  Fig. 5 ). Furthermore, Sp1 knockdown almost completely eliminated Tat occupancy at the promoter, decreased CycT1 and Hexim1 occupancy and reduced the levels of Pol II CTD Ser2 phosphorylation ( Fig. 4c ), suggesting that Sp1 may participate in P-TEFb-7SK snRNP interactions at the viral promoter in vivo. Indeed, previous data suggest that Sp1 and P-TEFb interact in vivo and that the interaction activates HIV-1 transcription 29, 41, 42 .
DISCUSSION
Current models of HIV-1 transcription activation propose that Tat and P-TEFb are recruited to the promoter by binding to TAR on the nascent transcript. However, here we provide evidence that Tat and P-TEFb, in complex with the inhibitory 7SK snRNP, are loaded into HIV-1 PICs before transcription initiation and in the absence of TAR ( Figs. 2 and 4) . Further, we provide evidence that Tat can displace the 7SK snRNP to activate the Cdk9 kinase ( Fig. 1) , consistent with previous reports that Tat releases Hexim1 from the large and inactive P-TEFb complexes 23, 24, 30 and, notably, that this activation step occurs as TAR emerges on the transcript (Fig. 2) from a promoter-paused Pol II 7 . These results lead to a two-step model for Tat activation (Fig. 5a) . First, the catalytically inactive P-TEFb-7SK snRNP complex is recruited to the promoter with Tat, most likely as a preassembled complex ( Fig. 3) and through interactions with Sp1 or other basal transcription factors, and remains bound in promoter-paused transcription complexes ( Figs. 4  and 5a) . Second, the inhibitory 7SK snRNP is released by competitive binding of the Tat-P-TEFb complex to TAR as it is transcribed, thereby activating Cdk9 and Pol II CTD phosphorylation (Fig. 5a) . Notably, Tat and P-TEFb-7SK snRNP complexes are recruited to PICs even in a TAR-deleted promoter (Fig. 2d) and in the absence of transcription (Fig. 4a) , providing direct evidence that TAR does not function solely as a recruitment site for Tat and CycT1. Even though Tat assembles into PICs in the TAR-deleted promoter, it does not activate Cdk9 and the transcription complexes therefore remain incompetent for elongation ( Fig. 5b) . In this revised model, TAR provides the essential function of transferring Tat and CycT1 to the nascent RNA, displacing the inhibitory 7SK snRNP in the process (Fig. 5a) .
Several previous observations are consistent with this basic model of Tat activation: (i) P-TEFb has been found in HIV-1 PICs in the absence of Tat and remains associated with productive elongation complexes [31] [32] [33] [34] 43 ; (ii) Tat has been found in complexes with Pol II and HIV-1 PICs before synthesis of TAR 21, 35, 44 ; and Hexim1 overexpression inhibits Tat activation 45 . The finding that Tat is present in PICs is consistent with the observation that it stimulates HIV-1 transcription complex assembly 5 , perhaps by enhancing P-TEFb recruitment or stabilizing PICs at the promoter (Figs. 2 and 4) .
In our model, P-TEFb is transferred to the nascent RNA cotranscriptionally soon after TAR is synthesized, allowing Tat and CycT1 to bind and competitively displace the 7SK snRNP. We envision that the role of TAR in ejecting the inhibitory 7SK snRNP subunits ensures that Cdk9 becomes activated on the nascent RNA and effectively times the switch between initiation and elongation. The precise nature of the nascent RNA appears to be unimportant for triggering Cdk9 activation, as the Tat-TAR interaction can be functionally replaced by heterologous RNA-protein interactions when the Tat activation domain is fused to the cognate RNA-binding domain [46] [47] [48] [49] . Therefore, Tat-7SK snRNP complex is recruited to HIV-1 PICs containing the Pol IIa form and the basal transcription machinery (for example, Sp1, TBP), among other possible promoter-specific factors, and remains bound in the paused state. As transcription proceeds and TAR is synthesized, Tat facilitates the transfer of P-TEFb to the nascent RNA site. We propose that this Tat-TAR binding event competitively displaces 7SK snRNP and activates Cdk9 to phosphorylate Ser2 residues in the CTD (P) and assemble competent transcription elongation complexes containing a Pol IIo form. Hexim1 may dissociate from Larp7-7SK snRNA complexes, as it is not stably bound 30 and may be replaced by hnRNP proteins in a transcriptiondependent manner 59, 60 . (b) In the absence of TAR, Tat and P-TEFb do not transfer to the nascent RNA and evict the 7SK snRNP, preventing Ser2-CTD phosphorylation (P) and the formation of elongation complexes. a r t i c l e s it is not TAR per se but the protein-RNA binding step that dissociates 7SK snRNP and activates the P-TEFb kinase. In contrast, the Tat activation domain is indispensable for activation, consistent with the observation that it is the minimal domain required to displace Hexim1 from P-TEFb by competing for the same interaction surface on CycT1 as well as to activate Cdk9 (refs. 10, 23, 39) . Even when the Tat activation domain alone is recruited to the HIV-1 promoter (Supplementary Fig. 4) , it does not activate transcription, consistent with the idea that Tat does not dissociate the 7SK snRNP without the TAR-binding step (Figs. 2 and 5) . In agreement with the proposed cotranscriptional role for TAR, our ChIP data show that Tat cannot displace Hexim1 from the 7SK snRNP or increase Pol II Ser2 CTD phosphorylation when TAR is deleted (Fig. 2b,d) , although recombinant Tat can do so at high concentrations in vitro in the absence of template DNA or TAR (Fig. 1c) . We speculate that an additional step in which Tat does not activate the P-TEFb kinase until TAR is synthesized is not recapitulated under these in vitro conditions. It is noteworthy that both Tat and Hexim1 are able to bind to a 5′ region of 7SK snRNA in vitro 30, 38 , that Hexim1 possesses an argininerich motif similar to the RNA-binding domain of Tat 10 and that both compete for the same interaction surface on CycT1 (refs. 23, 39, 45) . These results provide evidence for molecular mimicry between the viral and host protein-RNA complexes (Tat-TAR and Hexim1-7SK snRNA) and suggest a competition model in which Tat takes the place of Hexim1 during the formation of transcription elongation complexes (Fig. 5) , consistent with the observation that Tat displaces Hexim1 from the 7SK snRNP. Our findings also help resolve two apparent paradoxes. First, drugs that impair Pol II activity, like actinomycin D, activate the HIV-1 promoter 50 , and notably, it stimulates the release of Hexim1 from the HIV-1 promoter, mimicking Tat (albeit not as efficiently) (Supplementary Fig. 6) . Second, drugs that reduce the levels of the inactive P-TEFb complex correspondingly reduce HIV-1 replication rates 51 .
There are striking similarities between Tat-P-TEFb loading at the HIV-1 promoter and transfer to the nascent pre-mRNA with cotranscriptional processes in which some pre-mRNA processing factors, such as the capping machinery and splicing factors, initially are loaded on a promoter-paused Pol II complex and are later transferred to the pre-mRNA 36, 52, 53 . The proposed cotranscriptional mechanism helps solve a longstanding puzzle as to why HIV-1 evolved the use of an RNA site, in this case TAR, to regulate transcription. In our model, TAR does not function like a simple enhancer to recruit Tat to the nascent RNA but rather allows an RNA-binding step to time the transition into productive elongation. This resembles the stimulatory effect of splicing factors on transcription elongation 54 . It remains to be determined if cellular promoters regulate P-TEFb activity by related mechanisms, but it is noteworthy that the 3′ untranslated of human I-mfa domain-containing (HIC) mRNA activates HIV-1 transcription elongation in a P-TEFb-dependent manner by displacing 7SK snRNA through a yet-unknown mechanism 55 . It is further possible that inactive P-TEFb complexes are assembled at cellular promoters and become activated by mechanisms that do not require a TARlike RNA element. Indeed, Gal4-Tat and Gal4-P-TEFb fusions can activate transcription of an HIV-1 promoter containing several Gal4 DNA-binding sites, although multiple sites are required and activation is weaker than with TAR 5,56 (I.D., unpublished data), implying that the normal pathway of activation may not be fully recapitulated by the artificial tethering of transcription factors or coactivators. Similarly, recruiting a Gal4-P-TEFb fusion to the hsp70 promoter in Drosophila melanogaster activates transcription in the absence of heat shock, but to a lower level than when activated by heat shock factor-1 (ref. 57).
HIV-1 transcription activation by Tat provides yet another example in which a virus exploits a cellular control mechanism: in this case, the coupling of transcription with pre-mRNA processing 53 through the use of a regulatory noncoding RNA. It will be interesting to test whether acetylation of the Tat activation domain, which enhances the formation of the elongation complex on TAR 49 , facilitates Tat-7SK snRNP assembly or the eviction of 7SK snRNP from the HIV-1 promoter. Understanding how Tat-7SK snRNP assembly and/or disassembly may be coordinated with the activity of the 7SK snRNA capping enzyme Mepce 20, 30 , with the activities of other elongation factors, such as DSIF and NELF, or with histone modifications at the HIV-1 promoter 6,26 also requires further investigation. Finally, as mentioned above, it seems unlikely that the assembly of inactive P-TEFb-7SK snRNP complexes at the HIV-1 promoter is unique, raising the question of whether other cellular genes use similar mechanisms to control the switch between initiation and elongation.
Note added in proof: While this paper was in the press, another paper 58 was published supporting the observation that Tat assembles into complexes with the 7SK snRNP in vivo.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
Note: Supplementary information is available on the Nature Structural & Molecular Biology website.
